Ohr Pharmaceutical to Announce Fiscal Fourth Quarter & Year End 2017 Results on Friday, December 15

Tuesday, December 12, 2017 1:02 PM UTC

NEW YORK, Dec. 12, 2017 -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that it will report financial results for its fiscal fourth quarter and year-ended September 30, 2017 prior to market open on Friday, December 15, 2017. The Company will also hold a live investor conference call and webcast at 8:30am Eastern Time.

Conference Call & Webcast
Friday, December 15 @ 8:30am Eastern Time
Domestic:			877-407-0789
International:			201-689-8562
Conference ID:			13674508
Webcast:			http://public.viavid.com/index.php?id=127596

Replays – Available through December 22, 2017
Domestic:			844-512-2921
International:			412-317-6671
Conference ID:			13674508

About Ohr Pharmaceutical, Inc.
Ohr Pharmaceutical, Inc. (Nasdaq:OHRP) is a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases. The company's lead drug candidate, Squalamine lactate ophthalmic solution, 0.2% (also known as OHR-102), is currently being studied using an eye drop formulation in an ongoing clinical trial (the MAKO study) for the treatment of the wet form of age-related macular degeneration. Topline data from the MAKO study is expected in early 2018. In addition, Ohr has a sustained-release micro fabricated micro-particle ocular drug delivery platform technology. Additional information on the company may be found at www.ohrpharmaceutical.com.

Contact:
Ohr Pharmaceutical, Inc.
Investor Relations
888-388-2327
[email protected]

LifeSci Advisors, LLC
Michael Wood
646-597-6983
[email protected]

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

Ohr Pharmaceutical to Announce Fiscal Fourth Quarter & Year End 2017 Results on Friday, December 15

Editor's Picks

Welcome to EconoTimes